Patterns of Relapse and Progression in Multiple Myeloma Patients Treated with Conventional and Novel Agent-Based Therapy: A Single Centre Experience

被引:0
|
作者
Monteith, Bethany E. [1 ]
Masih-Khan, Esther [2 ]
Atenafu, Eshetu C. [3 ]
Chen, Christine [4 ]
Prica, Anca [5 ]
Reece, Donna [6 ]
Tiedemann, Rodger [5 ]
Trudel, Suzanne [6 ]
Kukreti, Vishal [6 ]
机构
[1] Queens Univ, Dept Med, Kingston, ON K7L 3N6, Canada
[2] Princess Margaret Hosp, Dept Med Oncol & Hematol, Toronto, ON M4X 1K9, Canada
[3] Princess Margaret Hosp, Dept Biostat, Toronto, ON M4X 1K9, Canada
[4] Princess Margaret Hosp, Toronto, ON M4X 1K9, Canada
[5] Princess Margaret Canc Ctr, Dept Med Oncol & Hematol, Toronto, ON, Canada
[6] Princess Margaret Canc Ctr, Toronto, ON, Canada
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:4
相关论文
共 50 条
  • [1] Short progression-free survival predicts for poor overall survival in older patients with multiple myeloma treated upfront with novel agent-based therapy
    Migkou, Magdalini
    Kastritis, Efstathios
    Roussou, Maria
    Gkotzamanidou, Maria
    Gavriatopoulou, Maria
    Nikitas, Nikitas
    Mparmparoussi, Despina
    Matsouka, Charis
    Gika, Dimitra
    Terpos, Evangelos
    Dimopoulos, Meletios A.
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2011, 87 (04) : 323 - 329
  • [2] Short Progression Free Survival Predicts for Poor Overall Survival In Older Patients with Multiple Myeloma Treated Upfront with Novel Agent-Based Therapy.
    Kastritis, Efstathios
    Roussou, Maria
    Gavriatopoulou, Maria
    Migkou, Magdalini
    Gkotzamanidou, Maria
    Iakovaki, Marina
    Efstathiou, Eleni
    Terpos, Evangelos
    Dimopoulos, Meletios A.
    BLOOD, 2010, 116 (21) : 1251 - 1251
  • [3] Patterns of Relapse or Progression After Bortezomib-Based Salvage Therapy in Patients With Relapsed/Refractory Multiple Myeloma
    Ahn, Jae-Sook
    Jung, Sung-Hoon
    Yang, Deok-Hwan
    Bae, Soo-Young
    Kim, Yeo-Kyeoung
    Kim, Hyeoung-Joon
    Lee, Je-Jung
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2014, 14 (05): : 389 - 394
  • [4] REVERSIBILITY OF RENAL FAILURE IN MULTIPLE MYELOMA PATIENTS TREATED WITH BORTEZOMIB-BASED REGIMENS: A SINGLE CENTRE EXPERIENCE
    Stefanikova, Z.
    Roziakova, L.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 593 - 593
  • [5] EFFICACY OF THALIDOMIDE-BASED AND BORTEZOMIB-BASED REGIMENS IN THE FIRST RELAPSE OF 146 MULTIPLE MYELOMA PATIENTS: A SINGLE CENTRE EXPERIENCE
    Krejci, M.
    Adam, Z.
    Krivanova, A.
    Pour, L.
    Zahradova, L.
    Mayer, J.
    Vorlicek, J.
    Hajek, R.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 575 - 575
  • [6] EFFICACY OF LENALIDOMIDE-BASED AND BORTEZOMIB-BASED REGIMENS IN THE FIRST RELAPSE OF 144 MULTIPLE MYELOMA PATIENTS: A SINGLE CENTRE EXPERIENCE
    Krejci, M.
    Adam, Z.
    Pour, L.
    Krivanova, A.
    Sevcikova, E.
    Pelcova, J.
    Mayer, J.
    HAEMATOLOGICA, 2014, 99 : 638 - 638
  • [7] Osteonecrosis of the jaws in multiple myeloma patients treated with zoledronic acid: A single-centre experience
    Floridia, P. M.
    Mineo, G.
    Salemo, M.
    Russo, M.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 205 - 205
  • [8] Renal impairment is not an independent adverse prognostic factor in patients with multiple myeloma treated upfront with novel agent-based regimens
    Eleftherakis-Papapiakovou, Evangelos
    Kastritis, Esftathios
    Roussou, Maria
    Gkotzamanidou, Maria
    Grapsa, Irini
    Psimenou, Erasmia
    Nikitas, Nikitas
    Terpos, Evangelos
    Dimopoulos, Meletios A.
    LEUKEMIA & LYMPHOMA, 2011, 52 (12) : 2299 - 2303
  • [9] Treatment Patterns and Outcomes of Patients with CLL Treated with Chemoimmuno- and Novel Agent-Based Therapy: A Multicenter Study
    Mato, Anthony R.
    Yazdy, Maryam Sarraf
    Hill, Brian T.
    Shadman, Mazyar
    Tuncer, Hande
    Winter, Allison M.
    Kennard, Kaitlin
    Allan, John N.
    Ujjani, Chaitra S.
    Brander, Danielle M.
    Nabhan, Chadi
    Barr, Paul
    Brown, Jennifer R.
    Fox, Christopher P.
    Rhodes, Joanna
    Schuh, Anna
    Eyre, Toby A.
    Lamanna, Nicole
    Jain, Nitin
    Wierda, William G.
    Skarbnik, Alan P.
    Roeker, Lindsey E.
    Bannerji, Rajat
    Evens, Andrew M.
    Lansigan, Frederick
    Samp, Jennifer C.
    Nielsen, Jacqueline
    Pauff, James M.
    Kipps, Thomas J.
    Schuster, Stephen J.
    Follows, George A.
    Cheson, Bruce
    Eichhorst, Barbara
    BLOOD, 2018, 132
  • [10] LENALIDOMIDE AS RESCUE THERAPY IN MULTIPLE MYELOMA: A SINGLE-CENTRE EXPERIENCE
    Gamberi, B.
    Masini, L.
    Tognazzi, L.
    Merli, F.
    HAEMATOLOGICA, 2012, 97 : 626 - 626